New York AG Tish James sued former Emergent BioSolutions CEO over alleged insider trading around the COVID vaccine.
Robert Kramer, former CEO of Emergent BioSolutions, allegedly earned more than $10.1 million by executing trades with ...
Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its ...
Daily Voice on MSN
NY AG sues former Emergent CEO over insider trading
A former biotech CEO pocketed more than $10 million by selling company stock after learning of serious COVID-19 vaccine ...
New York's attorney general has filed an insider trading lawsuit against former Emergent BioSolutions CEO Robert Kramer, ...
New York Attorney General sued the former CEO of Emergent BioSolutions, Robert G. Kramer, for insider trading.
Former Emergent BioSolutions Inc. CEO Robert Kramer engaged in illegal insider trading during the Covid-19 pandemic, ...
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...
A former chief executive of Emergent BioSolutions was charged on Thursday with insider trading by New York Attorney General ...
Today Emergent BioSolutions, Inc. (NYSE: EBS) announced it made a voluntary prepayment of $100 million under its outstanding term loan facility in late December 2025 using cash on hand. “This ...
The New York attorney general’s office has filed suit against the former CEO of Emergent Biosolutions Inc., alleging insider trading, while at the same time announcing a settlement with the company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback